Abstract
Drug-induced changes in gene expression likely contribute to long-lasting structural and functional alterations in the brain’s reward circuitry and the persistence of addiction. Modulation of chromatin structure through covalent histone modifications has emerged as an important regulator of gene transcription in brain and increasing evidence suggests that misregulation of histone acetylation contributes to the establishment and maintenance of aberrant neuronal gene programs and behaviors associated with cocaine or amphetamine exposure. In this review, we summarize evidence supporting a role for histone acetylation in psychostimulant-induced plasticity and discuss findings from preclinical studies investigating histone deacetylase (HDAC) action and the use of small-molecule HDAC inhibitors (HDACis) to correct drug-mediated transcriptional dysregulation.
Keywords: Chromatin, drug addiction, histone acetylation, histone deacetylase (HDAC), histone methyltransferase (HMT), plasticity.
CNS & Neurological Disorders - Drug Targets
Title:Histone Deacetylases as Potential Targets for Cocaine Addiction
Volume: 14 Issue: 6
Author(s): Pamela J. Kennedy and Eric Harvey
Affiliation:
Keywords: Chromatin, drug addiction, histone acetylation, histone deacetylase (HDAC), histone methyltransferase (HMT), plasticity.
Abstract: Drug-induced changes in gene expression likely contribute to long-lasting structural and functional alterations in the brain’s reward circuitry and the persistence of addiction. Modulation of chromatin structure through covalent histone modifications has emerged as an important regulator of gene transcription in brain and increasing evidence suggests that misregulation of histone acetylation contributes to the establishment and maintenance of aberrant neuronal gene programs and behaviors associated with cocaine or amphetamine exposure. In this review, we summarize evidence supporting a role for histone acetylation in psychostimulant-induced plasticity and discuss findings from preclinical studies investigating histone deacetylase (HDAC) action and the use of small-molecule HDAC inhibitors (HDACis) to correct drug-mediated transcriptional dysregulation.
Export Options
About this article
Cite this article as:
Kennedy J. Pamela and Harvey Eric, Histone Deacetylases as Potential Targets for Cocaine Addiction, CNS & Neurological Disorders - Drug Targets 2015; 14 (6) . https://dx.doi.org/10.2174/1871527314666150529144804
DOI https://dx.doi.org/10.2174/1871527314666150529144804 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Functional Annotation of Genes Overlapping Copy Number Variants in Autistic Patients: Focus on Axon Pathfinding
Current Genomics Room for Improvement in the Pharmacological Treatment of Anxiety Disorders
Current Pharmaceutical Design Alzheimer’s Disease Amyloid Peptides Interact with DNA, As Proved by Surface Plasmon Resonance
Current Alzheimer Research Microfluidics for Monitoring Oxidative Stress and Antioxidant Capacity
Current Analytical Chemistry Potential Epigenetic Targets for Combating Alzheimer’s Disease
Mini-Reviews in Medicinal Chemistry Combination of Therapeutic Hypothermia and Other Neuroprotective Strategies after An Ischemic Cerebral Insult
Current Neuropharmacology Present Drug Therapy of Demyelinating Disorders
Current Drug Therapy Extraction, Characterization and In Vivo Neuromodulatory Activity of Phytosterols from Microalga Dunaliella Tertiolecta
Current Medicinal Chemistry Animal Models of Ejaculatory Behavior
Current Pharmaceutical Design The Potential Role of Functional Near-Infrared Spectroscopy as Clinical Biomarkers in Schizophrenia
Current Pharmaceutical Design Calpain-Associated Proteolytic Regulation of the Stromal Microenvironment in Cancer
Current Pharmaceutical Design History Repeats Itself: Pharmacodynamic Trends in the Treatment of Anxiety Disorders
Current Pharmaceutical Design Use of Highly Active Antiretroviral Therapy is Increasing in HIV Positive Severe Drug Users
Current HIV Research Muscarinic Acetylcholine Receptor-Interacting Proteins (mAChRIPs): Targeting the Receptorsome
Current Drug Targets L-Dopa Prodrugs: An Overview of Trends for Improving Parkinsons Disease Treatment
Current Pharmaceutical Design New Insights into HLA-G and Inflammatory Diseases
Inflammation & Allergy - Drug Targets (Discontinued) Homodimeric Enzymes as Drug Targets
Current Medicinal Chemistry Deposition of Ni/TiN Composite Coatings by a Plasma Assisted MOCVD Using an Organometallic Precursor
Micro and Nanosystems The Antagonists of Endothelin Receptors: Results and Perspectives
Current Pharmaceutical Analysis Carbonic Anhydrase Activation and the Drug Design
Current Pharmaceutical Design